Christine Oswald

Christine Oswald has over 18 years of experience in the field of Structural Biology of GPCRs. Christine began their career in 2003 as a Predoctoral Research Fellow at Chalmers Tekniska Högskola. Christine then went on to become a Postdoctoral Research Fellow at Karolinska Institutet in 2008, Johann Wolfgang Goethe-Universität Frankfurt am Main in 2010, and Københavns Universitet in 2013. In 2014, they joined Heptares Therapeutics Ltd. as a Senior Scientist, where they published in Nature (doi: 10. 1038/nature20606). Christine is currently a Principal Scientist at OMass Therapeutics, a role they have held since 2022.

Christine Oswald's education history includes a Doctor of Philosophy (PhD) (Dr. rer. nat.) from the University of Düsseldorf in 2008, a PhD student from Goethe University in 2004-2005, a diploma thesis project from Chalmers University of Technology in 2002, a Master of Science (Dipl.-Chem.) from Technical University of Munich in 1997-2002, and an Abitur from Voehlin Gymnasium Memmingen.